Inventor
THRASHER KENNETH JEFF
US26 patents
⚠️ This page may combine multiple inventors who share the name “THRASHER KENNETH JEFF”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
LILLY CO ELI
22 patentsUS6639076B1Oct 28, 2003
Growth hormone secretagogues
LILLY CO ELI25 citations90
US5401851AMar 28, 1995
Angiotensin II antagonists
LILLY CO ELI25 citations89
US6087378AJul 11, 2000
Pharmaceutical formulations and applications thereof for the treatment of estrogen deprivation syndrome
LILLY CO ELI5 citations73
US6075151AJun 13, 2000
Benzothiophene compounds, intermediates, processes, compositions, and methods
LILLY CO ELI9 citations73
US5843963ADec 1, 1998
Benzothiophene compounds, intermediates, processes, compositions, and methods
LILLY CO ELI8 citations73
US5693633ADec 2, 1997
Angiotensin II antagonists
LILLY CO ELI8 citations73
US5484780AJan 16, 1996
Angiotensin II antagonists
LILLY CO ELI8 citations71
US6440958B1Aug 27, 2002
Acrylic and propionic acid compounds, intermediates, processes, compositions, and methods
LILLY CO ELI3 citations62
US6350884B1Feb 26, 2002
Acrylic and propionic acid compounds, intermediates, processes, compositions, and method
LILLY CO ELI2 citations62
US6265575B1Jul 24, 2001
Antithrombotic diamines
LILLY CO ELI4 citations62
US5986109ANov 16, 1999
Benzothiophene compounds, intermediates, compositions, and methods
LILLY CO ELI1 citations62
US5981765ANov 9, 1999
Benzothiophene compounds, intermediates, compositions, and methods
LILLY CO ELI1 citations62
US5856339AJan 5, 1999
Benzothiophene compounds, intermediates, compositions, and methods
LILLY CO ELI2 citations62
US5556981ASep 17, 1996
Angiotensin II antagonist intermediates
LILLY CO ELI3 citations60
US6743794B2Jun 1, 2004
Methods and compounds for inhibiting MRP1
LILLY CO ELI7 citations58
US5969142AOct 19, 1999
Benzothiophene compounds, intermediates, compositions and methods
LILLY CO ELI0 citations52
US7037921B2May 2, 2006
Compounds and methods for inhibiting MRP1
LILLY CO ELI0 citations51
US6258826B1Jul 10, 2001
Pharmaceutical formulations and applications thereof for the treatment of estrogen deprivation syndrome
LILLY CO ELI1 citations51
US6992097B2Jan 31, 2006
Growth hormone secretagogues
LILLY CO ELI1 citations48
US7101891B2Sep 5, 2006
Compounds and pharmaceutical compositions for inhibiting MRP1
LILLY CO ELI0 citations41
US7125840B2Oct 24, 2006
Substituted dipeptides as growth hormone secretagogues
LILLY CO ELI0 citations40
US9776992B2Oct 3, 2017
1-oxo-1,2-dihydroisoquinolin-7-yl-(5-substituted-thiophen-2-yl)-sulfonamide compounds, formulations containing those compounds, and their use as AICARFT inhibitors in the treatment of cancers
LILLY CO ELI0 citations36
EMISPHERE TECH INC
2 patentsUS7662771B2Feb 16, 2010
Compounds, methods and formulations for the oral delivery of a glucagon-like peptide (GLP)-1 compound or a melanocortin-4 receptor (MC4) agonist peptide
EMISPHERE TECH INC7 citations71
US7947841B2May 24, 2011
Compounds, methods and formulations for the oral delivery of a glucagon-like peptide (GLP)-1 compound or a melanocortin-4 receptor (MC4) agonist peptide
EMISPHERE TECH INC2 citations58